erbB receptor expression patterns in human bladder cancer

Urology

Volumn 66, Issue 1, 2005, Pages 196-200

  Rajjayabun, P H ^b   Keegan, P E ^b   Lunec, J ^b   Mellon, J K ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4;

ARTICLE; BLADDER CANCER; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA;

FEMALE; HUMANS; MALE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; URINARY BLADDER NEOPLASMS;

EID: 22344437801     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2005.01.046     Document Type: Article

References (29)

1. N.M. Heney, S. Ahmed, M.J. Flanagan Superficial bladder cancer progression and recurrence J Urol 130 1983 1083 1086
2. C. Anderstrom, S. Johansson, S. Nilsson The significance of lamina propria invasion on the prognosis of patients with bladder tumours J Urol 124 1980 23 26
3. S. Kaubisch, B.L. Lum, J. Reese Stage T1 bladder cancer grade is the primary determinant for risk of muscle invasion J Urol 146 1991 28 31
4. D.R. Robinson, Y.M. Wu, S.F. Lin The protein tyrosine kinase family of the human genome Oncogene 19 2000 5548 5557
5. D.J. Sandweiss The immunising effect of the anti-ulcer factor in normal human urine (anthelone) against the experimental gastrojejunal (peptic) ulcer in dogs Gastroenterology 1 1943 965 969
6. S. Cohen Isolation of a mouse sub-maxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal J Biol Chem 237 1962 1555 1562
7. I. Alroy, Y. Yarden The ErbB signaling network in embryogenesis and oncogenesis signal diversification through combinatorial ligand-receptor interactions FEBS Lett 410 1997 83 86
8. K.L. Carraway, L.C. Cantley A neu acquaintance for erbB3 and erbB4 a role for receptor heterodimerization in growth signaling Cell 78 1994 5 8
9. I.M. Harwerth, W. Wels, B.M. Marte Monoclonal antibodies against the extracellular domain of the erbB-2 receptor function as partial ligand agonists J Biol Chem 267 1992 15160 15167
10. J.M. Daly, C.B. Jannot, R.R. Beerli Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumour cells Cancer Res 57 1997 3804 3811
11. R.R. Beerli, D. Graus-Porta, K. Woods-Cook Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2 Mol Cell Biol 15 1995 6496 6505
12. M. Hader, D. Stach-Machado, K.H. Pfluger Epidermal growth factor receptor expression, proliferation, and colony stimulating activity production in the urinary bladder carcinoma cell line 5637 J Cancer Res Clin Oncol 113 1987 579 585
13. U. Lonn, S. Lonn, S. Friberg Prognostic value of amplification of c-erb-B2 in bladder carcinoma Clin Cancer Res 1 1995 1189 1194
14. M. Underwood, J. Bartlett, J. Reeves C-erbB-2 gene amplification a molecular marker in recurrent bladder tumors? Cancer Res 55 1995 2422 2430
15. J.K. Mellon, J. Lunec, C. Wright C-erbB-2 in bladder cancer molecular biology, correlation with epidermal growth factor receptors and prognostic value J Urol 155 1996 321 326
16. H. Miyamoto, Y. Kubota, S. Noguchi c-erbB-2 gene amplification as a prognostic marker in human bladder cancer Urology 55 2000 679 683
17. M. Kohler, I. Janz, H.O. Wintzer The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance Anticancer Res 9 1989 1537 1547
18. P. Chen, K. Gupta, A. Wells Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis J Cell Biol 124 1994 547 555
19. O. Alper, E.S. Bergmann-Leitner, T.A. Bennett Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells J Natl Cancer Inst 93 2001 1375 1384
20. B. Brandt, A. Roetger, J.M. Bidart Early placenta insulin-like growth factor (pro-EPIL) is overexpressed and secreted by c-erbB-2-positive cells with high invasion potential Cancer Res 62 2002 1020 1024
21. D. Yu, S.S. Wang, K.M. Dulski c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties Cancer Res 54 1994 3260 3266
22. D.H. Yu, M.C. Hung Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells Oncogene 6 1991 1991 1996
23. R. Falcioni, A. Antonini, P. Nistico Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines Exp Cell Res 236 1997 76 85
24. B.S. Verbeek, S.S. Adriaansen-Slot, T.M. Vroom Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts FEBS Lett 425 1998 145 150
25. A. Roetger, A. Merschjann, T. Dittmar Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model Am J Pathol 153 1998 1797 1806
26. R. Srinivasan, R. Poulsom, H.C. Hurst Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types J Pathol 185 1998 236 245
27. N. Chow, S.H. Chan, T.S. Tzai Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder Clin Cancer Res 7 2001 1957 1962
28. T.T. Junttila, M. Laato, T. Vahlberg Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients Clin Can Res 9 2003 5346 5357
29. J. Baselga, L. Gianni, C. Geyer Future options with trastuzumab for primary systemic and adjuvant therapy Semin Oncol 31 suppl 2004 51 57